Link: https://www.rt.com/uk/529250-uk-cma-firms-nhs-medicine/
Accord Healthcare, Allergan Plc, Intas Pharmaceuticals, and Waymade Plc, were deemed to have contravened market rules, paying off their competition, increasing price of drugs when acting as the sole provider, and buying potential rivals to keep them out of the market. One case, the NHS was charged over £80 for a single pack of tablets that previously cost less than £1.